223 related articles for article (PubMed ID: 20621123)
1. 5-HT(3) receptors: role in disease and target of drugs.
Walstab J; Rappold G; Niesler B
Pharmacol Ther; 2010 Oct; 128(1):146-69. PubMed ID: 20621123
[TBL] [Abstract][Full Text] [Related]
2. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
Moulignier A
Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
[TBL] [Abstract][Full Text] [Related]
3. Serotonin induces the increase in intracellular Ca2+ that enhances neurite outgrowth in PC12 cells via activation of 5-HT3 receptors and voltage-gated calcium channels.
Homma K; Kitamura Y; Ogawa H; Oka K
J Neurosci Res; 2006 Aug; 84(2):316-25. PubMed ID: 16688720
[TBL] [Abstract][Full Text] [Related]
4. Impact of 5-HT₃ receptor antagonists on peripheral and central diseases.
Fakhfouri G; Rahimian R; Ghia JE; Khan WI; Dehpour AR
Drug Discov Today; 2012 Jul; 17(13-14):741-7. PubMed ID: 22390946
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses.
Dorostkar MM; Boehm S
J Neurochem; 2007 Jan; 100(2):395-405. PubMed ID: 17064350
[TBL] [Abstract][Full Text] [Related]
6. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
Gershon MD
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
[TBL] [Abstract][Full Text] [Related]
7. The neuronal 5-HT3 receptor network after 20 years of research--evolving concepts in management of pain and inflammation.
Faerber L; Drechsler S; Ladenburger S; Gschaidmeier H; Fischer W
Eur J Pharmacol; 2007 Mar; 560(1):1-8. PubMed ID: 17316606
[TBL] [Abstract][Full Text] [Related]
8. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
9. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
10. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
[TBL] [Abstract][Full Text] [Related]
11. Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.
Moura Barbosa AJ; De Rienzo F; Ramos MJ; Menziani MC
Eur J Med Chem; 2010 Nov; 45(11):4746-60. PubMed ID: 20724042
[TBL] [Abstract][Full Text] [Related]
12. Immunolabelling of the 5-HT 3B receptor subunit in the central and peripheral nervous systems in rodents.
Doucet E; Latrémolière A; Darmon M; Hamon M; Emerit MB
Eur J Neurosci; 2007 Jul; 26(2):355-66. PubMed ID: 17650111
[TBL] [Abstract][Full Text] [Related]
13. Do polymorphisms in the human 5-HT3 genes contribute to pathological phenotypes?
Krzywkowski K
Biochem Soc Trans; 2006 Nov; 34(Pt 5):872-6. PubMed ID: 17052218
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic antidepressants inhibit homomeric Cys-loop receptors by acting at different conformational states.
Gumilar F; Bouzat C
Eur J Pharmacol; 2008 Apr; 584(1):30-9. PubMed ID: 18314100
[TBL] [Abstract][Full Text] [Related]
15. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
Solt K; Stevens RJ; Davies PA; Raines DE
J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
[TBL] [Abstract][Full Text] [Related]
16. 5-HT(3) receptors: potential of individual isoforms for personalised therapy.
Niesler B
Curr Opin Pharmacol; 2011 Feb; 11(1):81-6. PubMed ID: 21345729
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the 5-HT3A receptor-mediated current by alkyl 4-hydroxybenzoates isolated from the seeds of Nelumbo nucifera.
Youn UJ; Lee JH; Lee YJ; Nam JW; Bae H; Seo EK
Chem Biodivers; 2010 Sep; 7(9):2296-302. PubMed ID: 20860031
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.
Rammes G; Eisensamer B; Ferrari U; Shapa M; Gimpl G; Gilling K; Parsons C; Riering K; Hapfelmeier G; Bondy B; Zieglgänsberger W; Holsboer F; Rupprecht R
Mol Psychiatry; 2004 Sep; 9(9):846-58, 818. PubMed ID: 15024394
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.
Krzywkowski K; Jensen AA; Connolly CN; Bräuner-Osborne H
Pharmacogenet Genomics; 2007 Apr; 17(4):255-66. PubMed ID: 17496724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
